It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Neurodevelopment requires precise regulation of gene expression, including post-transcriptional regulatory events such as alternative splicing and mRNA translation. However, translational regulation of specific isoforms during neurodevelopment and the mechanisms behind it remain unknown. Using RNA-seq analysis of mouse neocortical polysomes, here we report translationally repressed and derepressed mRNA isoforms during neocortical neurogenesis whose orthologs include risk genes for neurodevelopmental disorders. We demonstrate that the translation of distinct mRNA isoforms of the RNA binding protein (RBP), Elavl4, in radial glia progenitors and early neurons depends on its alternative 5′ UTRs. Furthermore, 5′ UTR-driven Elavl4 isoform-specific translation depends on upstream control by another RBP, Celf1. Celf1 regulation of Elavl4 translation dictates development of glutamatergic neurons. Our findings reveal a dynamic interplay between distinct RBPs and alternative 5′ UTRs in neuronal development and underscore the risk of post-transcriptional dysregulation in co-occurring neurodevelopmental disorders.
Translational regulation of isoforms in the developing nervous system is not well understood. Here, the authors report translational de-repression of RNA binding protein isoforms at their 5′UTRs in the neocortex and show the neurodevelopmental risk of post-transcriptional dysregulation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details












1 Rutgers University, Robert Wood Johnson Medical School, Department of Neuroscience and Cell Biology, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796); Rutgers University, Graduate Program in Neurosciences, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796)
2 Rutgers University, Robert Wood Johnson Medical School, Department of Neuroscience and Cell Biology, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796)
3 Rutgers University, Robert Wood Johnson Medical School, Department of Neuroscience and Cell Biology, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796); Rutgers University, Department of Cell Biology and Neuroscience, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796)
4 Croatian Institute for Brain Research, Center of Research Excellence for Basic, Clinical and Translational Neuroscience, University of Zagreb, School of Medicine, Zagreb, Croatia (GRID:grid.4808.4) (ISNI:0000 0001 0657 4636)
5 Rutgers University, Robert Wood Johnson Medical School, Department of Neuroscience and Cell Biology, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796); Rutgers University, Graduate Program in Neurosciences, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796); Croatian Institute for Brain Research, Center of Research Excellence for Basic, Clinical and Translational Neuroscience, University of Zagreb, School of Medicine, Zagreb, Croatia (GRID:grid.4808.4) (ISNI:0000 0001 0657 4636)
6 Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, Signaling Research Centers BIOSS and CIBSS, University of Freiburg, Freiburg, Germany (GRID:grid.5963.9)
7 Department of Physiology, Keio University School of Medicine, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959)
8 Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes)-UMR 6290, Rennes, France (GRID:grid.410368.8) (ISNI:0000 0001 2191 9284)
9 Department of Statistics, Rutgers University, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796)
10 Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Seaver Autism Center, Icahn School of Medicine at Mount Sinai, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351); Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)
11 Rutgers University, Department of Cell Biology and Neuroscience, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796)